N/A
N=10
Transcranial Magnetic Stimulation for Children With Tourette's Syndrome
Tourette Syndrome
Bottom Line
View on ClinicalTrials.gov: NCT02356003 ↗Enrolled (actual)
10
Serious AEs
0.0%
Results posted
Apr 2020
Primary outcome: Primary: Yale Global Tic Severity Scale — 64.40; 26.40 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Low frequency repetitive transcranial magnetic stimulation (Device)
- Age
- Pediatric · 7+ yrs
- Sex
- Male
- Sponsor
- University of Calgary
- Primary completion
- Dec 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Yale Global Tic Severity Scale |
64.40; 26.40 | — |
| SECONDARY Glutamate Concentration |
14.2; 13.4 | — |
| SECONDARY Functional Connectivity |
1.89 | — |
Summary
Tics are the core symptom of Tourette syndrome. These are repetitive, sudden, semi-voluntary movements or sounds. In some children, these tics can be especially bad and require treatment, however, options are limited. It is only with time and practice that youth with Tourette syndrome are better able to suppress their tics. For these reasons, new interventions are needed. The investigators will target a brain region involved in tics called the supplementary motor area. Using low frequency repetitive transcranial magnetic stimulation, the investigators will inhibit the activity, in a similar way to the tic suppression that develops with age. The investigators propose the following objectives: (Aim 1) The investigators hypothesize that Tourette syndrome symptom severity (as measured by the Yale Global Tic severity Scale) will decrease with low frequency repetitive transcranial magnetic stimulation targeting the supplementary motor area. (Aim 2) The investigators further hypothesize that improvement in Tourette syndrome symptoms will be moderated by low frequency repetitive transcranial magnetic stimulation induced changes in GABA and glutamate in the supplementary motor area, and changes in the functional connectivity between the supplementary motor area and primary motor cortex. Eleven children (7-12 years of age) with Tourette syndrome will be undergo low frequency repetitive transcranial magnetic stimulation (five times a week for three weeks). After the three weeks, they will look for changes in tic severity and brain chemistry and function. By developing a novel avenue for treating Tourette syndrome, they can directly impact the care of children by reducing the severity of tics and improving quality of life.
Eligibility Criteria
Inclusion Criteria
- Males
- Right-handed
Exclusion Criteria
- Female
- Left-handed
- Comorbid Attention Deficit Hyperactivity Disorder
Data sourced from ClinicalTrials.gov (NCT02356003). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.